(VIANEWS) – Novartis AG (NVS), Northern Technologies International Corporation (NTIC), Provident Financial Holdings (PROV) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Novartis AG (NVS)
85.33% Payout Ratio
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. It offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $4.1.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 24.91. Meaning, the purchaser of the share is investing $24.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.15%.
Moving Average
Novartis AG’s worth is under its 50-day moving average of $103.19 and higher than its 200-day moving average of $100.31.
Yearly Top and Bottom Value
Novartis AG’s stock is valued at $102.13 at 07:23 EST, under its 52-week high of $108.78 and way higher than its 52-week low of $79.98.
2. Northern Technologies International Corporation (NTIC)
82.35% Payout Ratio
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Earnings Per Share
As for profitability, Northern Technologies International Corporation has a trailing twelve months EPS of $0.34.
PE Ratio
Northern Technologies International Corporation has a trailing twelve months price to earnings ratio of 41.44. Meaning, the purchaser of the share is investing $41.44 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.75%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Northern Technologies International Corporation’s EBITDA is 1.66.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.1%, now sitting on 80.13M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jan 30, 2024, the estimated forward annual dividend rate is 0.28 and the estimated forward annual dividend yield is 1.99%.
3. Provident Financial Holdings (PROV)
49.12% Payout Ratio
Provident Financial Holdings, Inc. operates as the holding company for Provident Savings Bank, F.S.B. that provides community banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. Its deposit products include checking, savings, and money market accounts, as well as time deposits; and loan portfolio consists of single-family, multi-family, commercial real estate, construction, mortgage, commercial business, and consumer loans. The company also offers investment services comprising the sale of investment products, such as annuities and mutual funds; and trustee services for real estate transactions. It operates through 12 full-service banking offices in Riverside County and one full-service banking office in San Bernardino County. The company was founded in 1956 and is based in Riverside, California.
Earnings Per Share
As for profitability, Provident Financial Holdings has a trailing twelve months EPS of $1.14.
PE Ratio
Provident Financial Holdings has a trailing twelve months price to earnings ratio of 12.57. Meaning, the purchaser of the share is investing $12.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.21%.
Moving Average
Provident Financial Holdings’s worth is higher than its 50-day moving average of $13.34 and way above its 200-day moving average of $12.83.
4. Stryker Corp (SYK)
44.51% Payout Ratio
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Earnings Per Share
As for profitability, Stryker Corp has a trailing twelve months EPS of $8.24.
PE Ratio
Stryker Corp has a trailing twelve months price to earnings ratio of 42.88. Meaning, the purchaser of the share is investing $42.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 9% and 16.8%, respectively.
Moving Average
Stryker Corp’s value is way higher than its 50-day moving average of $294.50 and way higher than its 200-day moving average of $286.71.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 19.89B for the twelve trailing months.
5. Diamond Hill Investment Group (DHIL)
41.44% Payout Ratio
Diamond Hill Investment Group, Inc., together with its subsidiaries, provides investment advisory and fund administration services in the United States. It sponsors, distributes, and offers investment advisory and related services to its clients. The company also provides fund administration services, including portfolio and regulatory compliance, treasury and financial oversight, and general business management and governance of the mutual fund complex, as well as oversight of back-office service providers, such as the custodian, fund accountant, and transfer agent. The company was founded in 1990 and is based in Columbus, Ohio.
Earnings Per Share
As for profitability, Diamond Hill Investment Group has a trailing twelve months EPS of $14.48.
PE Ratio
Diamond Hill Investment Group has a trailing twelve months price to earnings ratio of 10.61. Meaning, the purchaser of the share is investing $10.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.26%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.1%, now sitting on 137.85M for the twelve trailing months.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Volume
Today’s last reported volume for 1 is 1 which is 1% above its average volume of 1.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1%, now sitting on 1 for the twelve trailing months.